Is the only long term strategy to keeping everyone safe as we reopen our businesses.

We have developed and launched one of the world’s first rapid point-of-care lateral flow immunoassays to aid in the diagnosis of coronavirus infection.

The test detects both early marker and late marker, IgM/IgG antibodies in human finger-prick (capillary) or venous whole blood, serum, and plasma samples.

How it Works

Steps:

1. Collect blood/serum/plasma sample.
2. Add blood/serum/plasma sample to sample well.
3. Place 2-3 drops of buffer in sample well.
4. Read results after 10 minutes and no more than 15 minutes.

Fast

• 10-15 minutes per test
• Intuitive visual interpretation
• No special equipment needed

Precise

• Works with whole blood, serum, & plasma
• Tests for both IgM and IgG antibodies
• Validated using PCR